TWM501839U - Wound dressing - Google Patents
Wound dressing Download PDFInfo
- Publication number
- TWM501839U TWM501839U TW103221183U TW103221183U TWM501839U TW M501839 U TWM501839 U TW M501839U TW 103221183 U TW103221183 U TW 103221183U TW 103221183 U TW103221183 U TW 103221183U TW M501839 U TWM501839 U TW M501839U
- Authority
- TW
- Taiwan
- Prior art keywords
- capillary
- wound
- wound dressing
- layer
- millimeters
- Prior art date
Links
- 239000000463 material Substances 0.000 claims description 31
- 230000002745 absorbent Effects 0.000 claims description 25
- 239000002250 absorbent Substances 0.000 claims description 25
- 229920000642 polymer Polymers 0.000 claims description 9
- 239000000835 fiber Substances 0.000 claims description 6
- 108700005457 microfibrillar Proteins 0.000 claims description 5
- 239000002131 composite material Substances 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 239000000017 hydrogel Substances 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- 229920000098 polyolefin Polymers 0.000 claims description 3
- 229920000247 superabsorbent polymer Polymers 0.000 claims description 3
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 claims description 3
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 claims description 3
- 229920002379 silicone rubber Polymers 0.000 claims description 2
- 239000004945 silicone rubber Substances 0.000 claims description 2
- 239000012530 fluid Substances 0.000 abstract description 20
- 206010052428 Wound Diseases 0.000 description 92
- 208000027418 Wounds and injury Diseases 0.000 description 92
- 210000001519 tissue Anatomy 0.000 description 21
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000035876 healing Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 206010063560 Excessive granulation tissue Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001126 granulation tissue Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000009581 negative-pressure wound therapy Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000035752 proliferative phase Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
本創作係有關於一種傷口敷料,尤其是一種具有毛細微結構的傷口敷料。This creation relates to a wound dressing, especially a wound dressing having a capillary structure.
身體的傷口自然癒合是一個自損傷時開始作用的複雜過程。首先,身體通過經由血液流向傷口遞送蛋白質和其他凝血物質,以使傷害降至最低。血液凝塊以防止失血,同時細胞吞噬傷口處的細菌和殘骸。接下來,被稱為增殖期的癒合階段,身體開始修復自身,肉芽組織沉積於傷口創面。肉芽組織在傷口上提供基礎結構,細胞可從傷口的週邊向內部遷移以合圍關閉傷口。最後,隨著時間推移形成疤痕。The natural healing of the wound in the body is a complex process that begins when it is damaged. First, the body delivers protein and other blood clotting substances through the flow of blood to the wound to minimize damage. The blood clots to prevent blood loss, while the cells devour the bacteria and debris at the wound. Next, called the healing phase of the proliferative phase, the body begins to repair itself and the granulation tissue deposits on the wound surface. The granulation tissue provides a foundation on the wound, and the cells can migrate from the periphery of the wound to the inside to close the wound. Finally, scars form over time.
習知的傷口敷料僅採用物理吸附的方式,吸出所有傷口滲出的血液及組織液,使傷口保持乾燥。然而,習知的傷口敷料並無法控制傷口周邊的環境溼度,過度乾燥的環境反而會影響傷口的癒合。Conventional wound dressings only use physical adsorption to aspirate all blood and tissue fluid exuded from the wound to keep the wound dry. However, conventional wound dressings do not control the ambient humidity around the wound, and an excessively dry environment can affect the healing of the wound.
一種可以在增殖期期間利用控制傷口溼度促進自然癒合過程的技術被稱作負壓傷口治療(negative pressure wound treatment,NPWT)。負壓傷口治療是利用簡易的負壓 源,例如真空幫浦,結合封口貼布、軟性吸盤與生物相容性孔隙材料,在傷口內形成負壓環境,抽取傷口膿液及感染物質、吸引健康組織液維持潮濕的治療環境、並促進周遭血液微循環而達到加速傷口癒合的效果。負壓傷口治療利用身體的自然癒合過程,可以有效促進血液流至傷口區域,刺激傷口上方肉芽組織的形成和健康組織的遷移。負壓傷口治療通過移除從傷口滲出的流體而抑制細菌生長。One technique that can utilize the control of wound moisture to promote a natural healing process during the proliferative phase is known as negative pressure wound treatment (NPWT). Negative pressure wound therapy is the use of simple negative pressure Sources, such as vacuum pumps, combined with seal patches, soft suction cups, and biocompatible pore materials to create a negative pressure environment within the wound, extract wound pus and infectious material, attract healthy tissue fluids to maintain a moist therapeutic environment, and promote peripherals The blood microcirculation achieves the effect of accelerating wound healing. Negative pressure wound treatment utilizes the body's natural healing process to effectively promote blood flow to the wound area, stimulating the formation of granulation tissue above the wound and the migration of healthy tissue. Negative pressure wound therapy inhibits bacterial growth by removing fluid oozing from the wound.
然而,負壓傷口治療係利用負壓源維持敷料中的負壓環境,而所吸出的多餘組織液則需利用管線遞送至儲液罐儲存。故在習知的負壓傷口治療系統中,除了與傷口創面接觸的敷料外,仍須包含提供負壓來源的幫浦、用於連接的管線以及儲存多餘組織液的儲液罐等等元件。這些元件的設置不僅是更換敷料時引起不便,更會限制患者的移動。However, negative pressure wound therapy uses a negative pressure source to maintain a negative pressure environment in the dressing, and the excess tissue fluid that is aspirated is delivered to the reservoir for storage. Therefore, in the conventional negative pressure wound treatment system, in addition to the dressing in contact with the wound surface of the wound, it is necessary to include a pump for providing a source of negative pressure, a line for connection, and a reservoir for storing excess tissue fluid. The setting of these components not only causes inconvenience when changing the dressing, but also limits the movement of the patient.
因此,目前仍需要一種簡便的傷口敷料,其不需搭配負壓源與管線的設置,而仍可控制傷口環境的溼度,持續吸附傷口處的多餘組織液,又不會使傷口表面過度乾燥。Therefore, there is still a need for a simple wound dressing that does not require the setting of a negative pressure source and a pipeline, but can still control the humidity of the wound environment and continuously adsorb excess tissue fluid at the wound without excessively drying the wound surface.
有鑑於此,本創作的目的係提供一種輕便的傷口敷料,其藉由毛細微結構層以及吸收層的設置,可持續吸收傷口處多餘的組織液,使傷口處於潮溼環境而不出現浸潤現象,進而幫助傷口癒合。In view of this, the purpose of the present invention is to provide a lightweight wound dressing which can continuously absorb excess tissue fluid at the wound by the arrangement of the capillary microstructure layer and the absorbent layer, so that the wound is in a humid environment without infiltration, and thus Help the wound heal.
本創作提供一種傷口敷料,其包含背材;吸收層,位於背材之上:以及毛細微結構層,且位於吸收層之上,其中,毛細微結構層具有複數個毛細微結構。The present invention provides a wound dressing comprising a backing material; an absorbent layer on top of the backing material: and a capillary microstructured layer on top of the absorbent layer, wherein the capillary microstructured layer has a plurality of capillary microstructures.
依據本創作之一實施方式,前述毛細微結構為微孔狀結構且各微孔狀結構之孔徑係介於0.6毫米(mm)至2.5毫米(mm)之間,前述毛細微結構之表面積總和與前述毛細微結構層之表面積之比例係介於45%至60%之間,且前述毛細微結構層之高度係介於5毫米(mm)至20毫米(mm)之間。According to one embodiment of the present invention, the capillary structure is a microporous structure and the pore size of each microporous structure is between 0.6 mm (mm) and 2.5 mm (mm), and the total surface area of the capillary microstructure is The ratio of the surface area of the aforementioned capillary microstructure layer is between 45% and 60%, and the height of the aforementioned capillary microstructure layer is between 5 mm (mm) and 20 mm (mm).
依據本創作之一實施方式,前述毛細微結構為微纖毛狀結構且各微纖毛狀結構間的距離係介於0.3毫米(mm)至1.25毫米(mm)之間,前述毛細微結構之表面積總和與前述毛細微結構層之表面積之比例係介於5%至20%之間,且前述毛細微結構層之高度係介於5毫米(mm)至20毫米(mm)之間。According to one embodiment of the present invention, the capillary structure is a microfibrillar structure and the distance between each microfibrillar structure is between 0.3 mm (mm) and 1.25 mm (mm), and the surface area of the capillary microstructure is summed. The ratio to the surface area of the aforementioned capillary microstructure layer is between 5% and 20%, and the height of the aforementioned capillary microstructure layer is between 5 millimeters (mm) and 20 millimeters (mm).
依據本創作之一實施方式,前述毛細微結構層經機械方式柔嫩化,以增加毛細微結構層的柔軟度與彈性。According to one embodiment of the present invention, the capillary microstructure layer is mechanically softened to increase the softness and elasticity of the capillary microstructure layer.
依據本創作之一實施方式,前述毛細微結構層之材料包含生物相容性的聚烯烴類高分子、聚酯類高分子、矽膠、四氟乙烯聚合物或其複合物。According to an embodiment of the present invention, the material of the capillary microstructure layer comprises a biocompatible polyolefin polymer, a polyester polymer, a silicone rubber, a tetrafluoroethylene polymer or a composite thereof.
依據本創作之一實施方式,前述吸收層之厚度係介於2毫米(mm)至20毫米(mm)之間。According to one embodiment of the present invention, the thickness of the absorbent layer is between 2 millimeters (mm) and 20 millimeters (mm).
依據本創作之一實施方式,前述吸收層之材料包含纖維、纖維海棉、泡沫材料、超級吸收聚合物、水凝膠材料、凝膠材料或其組合。According to one embodiment of the present invention, the material of the absorbent layer comprises fibers, fiber sponges, foams, superabsorbent polymers, hydrogel materials, gel materials, or combinations thereof.
依據本創作之一實施方式,前述背材係為不可滲透彈性膜。According to one embodiment of the present invention, the aforementioned backing material is an impermeable elastic film.
上述創作的內容旨在提供本揭示內容的簡化摘要,以使閱讀者對本揭示內容具備基本的理解。此創作內容並非本揭示內容的完整概述,且其用意並非在指出本創作實施例的重要/關鍵元件或界定本創作的範圍。在參閱下文實施方式後,本創作所屬技術領域中具有通常知識者當可輕易瞭解本創作之基本精神以及本創作所採用之技術手段與實施態樣。The above-identified content is intended to provide a simplified summary of the disclosure in order to provide a basic understanding of the disclosure. This written content is not a complete overview of the present disclosure, and is not intended to identify important/critical elements of the present embodiments or to define the scope of the present invention. After referring to the following embodiments, those having ordinary knowledge in the technical field of the present invention can easily understand the basic spirit of the present creation and the technical means and implementation manners adopted by the present creation.
100‧‧‧傷口敷料100‧‧‧Wound dressing
110‧‧‧背材110‧‧‧ Backing
120‧‧‧吸收層120‧‧‧absorbing layer
130‧‧‧毛細微結構層130‧‧‧Capillary microstructure layer
131‧‧‧毛細微結構131‧‧‧Capillary microstructure
H1、H2‧‧‧高度H1, H2‧‧‧ height
第1圖係繪示本創作之傷口敷料之側面結構示意圖。Figure 1 is a schematic view showing the side structure of the wound dressing of the present invention.
第2圖係繪示本創作之傷口敷料之毛細微結構層之一實施例之局部放大圖。Figure 2 is a partial enlarged view of one embodiment of the capillary structure of the wound dressing of the present invention.
第3圖係繪示本創作之傷口敷料之毛細微結構層之另一實施例之局部放大圖。Figure 3 is a partial enlarged view of another embodiment of the capillary layer of the wound dressing of the present invention.
以下將參照相關圖式,說明依本創作之傷口敷料之實施例,為使便於理解,下述實施例中之相同元件係以相同之符號標示來說明。在下面的敘述中,將會介紹上述之傷口敷料的例示結構。為了容易瞭解所述實施例之故,下面將會提供不少技術細節。當然,並不是所有的實施例皆需要這些技術細節。同時,一些廣為人知之結構或元件,僅會以示意的方式在圖式中繪出,以適當地簡化圖式內容。所使用之圖式,其主旨僅為示意及輔助說明書之用,未必為本創作實施後之真實比例與精準配置,故不應就所附之圖式的比例與配 置關係解讀、侷限本創作於實際實施上的權利範圍。The embodiments of the wound dressings according to the present invention will be described below with reference to the related drawings. For ease of understanding, the same elements in the following embodiments are denoted by the same reference numerals. In the following description, an exemplary structure of the wound dressing described above will be described. In order to facilitate an understanding of the described embodiments, a number of technical details are provided below. Of course, not all embodiments require these technical details. At the same time, some well-known structures or elements are only shown in the drawings in a schematic manner to appropriately simplify the contents of the drawings. The schematics used are for the purpose of illustration and supplementary instructions. They are not necessarily true proportions and precise configurations after the implementation of the creation. Therefore, the proportions and matching of the attached drawings should not be used. Interpretation of relationships, limitations on the scope of the scope of the creation of the actual implementation.
本創作之優點、特徵以及達到之技術方法將參照例示性實施例及所附圖式進行更詳細地描述而更容易理解,且本創作或可以不同形式來實現,故不應被理解僅限於此處所陳述的實施例,相反地,對所屬技術領域具有通常知識者而言,所提供的實施例將使本揭露更加透徹與全面且完整地傳達本創作的範疇,且本創作將僅為所附加的申請專利範圍所定義。The advantages, features, and technical methods of the present invention will be more readily understood by referring to the exemplary embodiments and the accompanying drawings, and the present invention may be implemented in various forms and should not be construed as limited thereto. The embodiments set forth herein, and vice versa, will provide a more thorough and complete and complete disclosure of the scope of the present invention, and the present invention will only be The scope of the patent application is defined.
而除非另外定義,所有使用於後文的術語(包含科技及科學術語)與專有名詞,於實質上係與本創作所屬該領域的技術人士一般所理解之意思相同,而例如於一般所使用的字典所定義的那些術語應被理解為具有與相關領域的內容一致的意思,且除非明顯地定義於後文,將不以過度理想化或過度正式的意思理解。Unless otherwise defined, all terms (including scientific and scientific terms) and proper nouns used hereinafter are used in the same meaning as commonly understood by those skilled in the art to which the present invention belongs. Those terms defined by the dictionary should be understood to have the meaning consistent with the relevant art, and will not be understood in an excessively idealized or overly formal meaning unless explicitly defined in the following.
請參閱第1圖,第1圖係本創作之傷口敷料100之側面結構示意圖。如第1圖所示,本創作之傷口敷料100的結構依序包含背材110、吸收層120以及毛細微結構層130。Please refer to FIG. 1 , which is a schematic view showing the side structure of the wound dressing 100 of the present invention. As shown in FIG. 1, the structure of the wound dressing 100 of the present invention sequentially includes a backing material 110, an absorbent layer 120, and a capillary microstructure layer 130.
背材110配置在傷口上方,在一實施方式中,背材110邊緣靠近傷口之一側可具有黏合劑(未繪示),使背材110與傷口周圍皮膚緊密密封。在另一實施方式中,背材110係藉由外貼式膠帶黏貼於傷口周圍的皮膚,使傷口周圍形成密封環境。因此,背材110可以作為微生物屏障以防止污染物進入傷口,並使吸收層120以及毛細微結構層130固定於傷口上方。在實施上,背材110之材料可以是濕氣滲透膜,以 促進在傷口和大氣之間的氧和濕氣的交換。背材110也可以是不可滲透膜或剛性部件。考量使用便利性及針對傷口的貼合性,在本創作之一實施方式中,背材110係為不可滲透彈性膜。The backing material 110 is disposed above the wound. In one embodiment, the edge of the backing material 110 adjacent to one side of the wound may have an adhesive (not shown) to provide a tight seal between the backing material 110 and the skin surrounding the wound. In another embodiment, the backing material 110 is adhered to the skin surrounding the wound by an adhesive tape to create a sealed environment around the wound. Thus, the backing material 110 can serve as a microbial barrier to prevent contaminants from entering the wound and to secure the absorbent layer 120 and the capillary microstructure layer 130 above the wound. In practice, the material of the backing material 110 may be a moisture permeable membrane to Promotes the exchange of oxygen and moisture between the wound and the atmosphere. The backing material 110 can also be an impermeable membrane or a rigid component. Considering ease of use and fit to the wound, in one embodiment of the present invention, the backing material 110 is an impermeable elastic film.
吸收層120位於背材110之上,用以提供對組織液的吸收力,且背材110之表面積大於吸收層120之表面積。吸收層120之厚度H1可依其所需之最大液體儲存空間而調整,在實施上,吸收層120之厚度H1約可介於2毫米(mm)至20毫米(mm)之間。在本創作之一實施方式中,吸收層120之材料包含,但不限於,纖維、纖維海棉、泡沫材料、超級吸收聚合物、水凝膠材料、凝膠材料或其組合。The absorbent layer 120 is positioned over the backing material 110 to provide absorption of tissue fluid, and the surface area of the backing material 110 is greater than the surface area of the absorbent layer 120. The thickness H1 of the absorbent layer 120 can be adjusted according to the maximum liquid storage space required. In practice, the thickness H1 of the absorbent layer 120 can be between about 2 millimeters (mm) and 20 millimeters (mm). In one embodiment of the present invention, the material of the absorbent layer 120 comprises, but is not limited to, fibers, fiber sponges, foams, superabsorbent polymers, hydrogel materials, gel materials, or combinations thereof.
毛細微結構層130位於吸收層120上,具有複數個毛細微結構131,且吸收層120之表面積大於或等於毛細微結構層130之表面積,以提供均勻的吸收力。毛細現象(又稱毛細管作用)是指液體在細管狀物體內側,由於內聚力與附著力的差異、克服地心引力而上升的現象。毛細微結構層130與傷口直接接觸,當傷口所流出的組織液之內聚力與對毛細微結構層130之附著力大於組織液的重力時,組織液即可藉由毛細現象擴散至吸收層120端。而藉由吸收層120之吸收力,可持續吸附傷口上的多餘組織液,使傷口處於潮溼環境而不出現浸潤現象,可有效幫助傷口癒合。此外,藉由毛細微結構層130之設置,傷口並不直接與吸收層120接觸,故不會有習知傷口敷料因持續吸收組織液而使傷口表面過度乾燥的問題。The capillary microstructure layer 130 is located on the absorbent layer 120 having a plurality of capillary microstructures 131, and the surface area of the absorbent layer 120 is greater than or equal to the surface area of the capillary microstructure layer 130 to provide uniform absorption. Capillary phenomenon (also known as capillary action) refers to the phenomenon that the liquid rises inside the thin tubular object due to the difference in cohesion and adhesion and overcomes gravity. The capillary microstructure layer 130 is in direct contact with the wound. When the cohesion of the tissue fluid flowing out of the wound and the adhesion to the capillary microstructure layer 130 is greater than the gravity of the tissue fluid, the tissue fluid can be diffused to the end of the absorption layer 120 by capillary action. By the absorption force of the absorption layer 120, the excess tissue liquid on the wound can be continuously adsorbed, so that the wound is in a humid environment without infiltration, which can effectively help the wound to heal. In addition, by the arrangement of the capillary microstructure layer 130, the wound is not directly in contact with the absorbent layer 120, so there is no problem that the conventional wound dressing excessively dries the wound surface due to continuous absorption of the tissue fluid.
在本創作之一實施方式中,毛細微結構層130具有 複數個毛細微結構131,毛細微結構131為微孔狀,各微孔狀毛細微結構131之孔徑係介於0.6毫米(mm)至2.5毫米(mm)之間,複數個微孔狀的毛細微結構131之傷口接觸面之表面積總和與毛細微結構層130之傷口接觸面之表面積之比例係介於45%至60%之間,且毛細微結構層130之高度H2係介於5毫米(mm)至20毫米(mm)之間,微孔狀的毛細微結構131直接與傷口接觸,傷口處的多餘組織液即藉由毛細現象擴散至吸收層120,如第2圖所示。In one embodiment of the present invention, the capillary microstructure layer 130 has a plurality of capillary microstructures 131, the capillary microstructures 131 are microporous, and the pore size of each of the microporous capillary microstructures 131 is between 0.6 mm (mm) and 2.5 mm (mm), and a plurality of microporous capillaries The ratio of the surface area of the wound contact surface of the microstructure 131 to the surface area of the wound contact surface of the capillary microstructure layer 130 is between 45% and 60%, and the height H2 of the capillary microstructure layer 130 is between 5 mm ( Between mm and 20 mm (mm), the microporous capillary microstructure 131 is in direct contact with the wound, and the excess tissue fluid at the wound is diffused to the absorbent layer 120 by capillary action, as shown in FIG.
在本創作之另一實施方式中,毛細微結構層130具有的毛細微結構131為微纖毛狀,各微纖毛狀毛細微結構131間的距離係介於0.3毫米(mm)至1.25毫米(mm)之間,複數個微纖毛狀的毛細微結構131之傷口接觸面之表面積總和與毛細微結構層130之傷口接觸面之表面積之比例係介於5%至20%之間,且毛細微結構層130之高度H2係介於5毫米(mm)至20毫米(mm)之間,纖毛狀的毛細微結構131直接與傷口接觸,傷口處的多餘組織液藉由纖毛狀的毛細微結構131間產生的毛細現象而擴散至吸收層120,如第3圖所示。In another embodiment of the present invention, the capillary microstructures 130 have a capillary structure 131 that is microfibrillated, and the distance between each of the microfibrillar capillary microstructures 131 ranges from 0.3 millimeters (mm) to 1.25 millimeters (mm). Between the total surface area of the wound contact surface of the plurality of microfibrillated capillary microstructures 131 and the surface area of the wound contact surface of the capillary microstructure layer 130 is between 5% and 20%, and the capillary microstructure The height H2 of the layer 130 is between 5 mm (mm) and 20 mm (mm), and the ciliated capillary microstructure 131 is in direct contact with the wound, and the excess tissue fluid at the wound is produced by the ciliated capillary microstructure 131. The capillary phenomenon spreads to the absorbing layer 120 as shown in FIG.
考慮到患者使用傷口敷料100時之舒適性,直接與傷口接觸的毛細微結構層130可選擇性地經機械方式柔嫩化,以增加毛細微結構層130的柔軟度與彈性。考量製造時的加工性以及患者在使用時的舒適性,在本創作之一實施方式中,毛細微結構層130之材料可以例如是生物相容性的聚烯烴類高分子、聚酯類高分子、矽膠、四氟乙烯聚合物或其複合物。In view of the comfort of the patient when using the wound dressing 100, the capillary microstructure layer 130 that is in direct contact with the wound can be selectively mechanically softened to increase the softness and elasticity of the capillary microstructure layer 130. Considering the processability at the time of manufacture and the comfort of the patient during use, in one embodiment of the present invention, the material of the capillary microstructure layer 130 may be, for example, a biocompatible polyolefin polymer or a polyester polymer. , silicone, tetrafluoroethylene polymer or a composite thereof.
據此,當使用本創作之傷口敷料100時,在以背材 110形成密封傷口的狀態下,傷口上的多餘組織液因毛細現象經由毛細微結構層130而擴散至吸收層120,藉由吸收層120所提供的吸收力即可持續產生吸附多餘組織液的效果。本創作之傷口敷料100可適度的吸附傷口上的多餘組織液,使傷口維持適當的溼度,以使傷口處維持良好的血液循環效果,進而促進傷口癒合。Accordingly, when using the wound dressing 100 of the present invention, In the state in which the sealed wound is formed, the excess tissue fluid on the wound diffuses to the absorbent layer 120 via the capillary microstructure layer 130 due to the capillary phenomenon, and the absorption force provided by the absorbent layer 120 can continuously produce the effect of adsorbing the excess tissue fluid. The wound dressing 100 of the present invention can appropriately absorb excess tissue liquid on the wound to maintain proper humidity of the wound, so as to maintain a good blood circulation effect at the wound, thereby promoting wound healing.
本創作具有以下幾個優點:This creation has the following advantages:
1.相較習知技術所使用的負壓傷口治療,因本創作之傷口敷料不需額外設置負壓源、負壓控制器、管線以及儲液罐等元件,故在使用上較為輕便,亦不會影響患者的行動。1. Compared with the vacuum wound treatment used in the prior art, the wound dressing of the present invention does not need to be provided with a negative pressure source, a negative pressure controller, a pipeline, a liquid storage tank and the like, so it is lighter in use. Does not affect the patient's actions.
2.操作方式簡便,外觀與一般傷口敷料接近。2. The operation mode is simple and the appearance is close to the general wound dressing.
3.因僅有多餘的組織液會擴散至吸收層,相較於一般傳統的傷口敷料,本創作之傷口敷料可更容易控制密封環境中的溼度,不會因吸收材料直接與傷口接觸而反而使傷口表面過度乾燥。3. Since only excess tissue fluid will diffuse to the absorbent layer, the wound dressing of the present invention can more easily control the humidity in the sealed environment without the direct contact of the absorbent material with the wound, instead of the conventional wound dressing. The wound surface is overly dry.
4.藉由毛細微結構層之設置,儲存於吸收層中的組織液不會使傷口產生浸潤現象。4. By the arrangement of the capillary microstructure layer, the tissue fluid stored in the absorbent layer does not cause the wound to infiltrate.
5.在傷口癒合不同程度的階段中可選用具有不同毛細微結構層之傷口敷料,藉由不同的毛細微結構層提供不同的吸附力,以配合不同階段會有的滲液程度。5. Wound dressings with different capillary microstructure layers can be used in different stages of wound healing, and different capillary layers provide different adsorption forces to match the degree of exudation at different stages.
承上所述,依本創作之傷口敷料可以吸附多餘的組織液,使傷口維持在適當的溼度中,且不會使傷口過度乾燥,可促進傷口的癒合。此外,相較於習知技術中使用的負 壓傷口治療,使用本創作之傷口敷料還具有輕便、操作簡單等優點。As described above, the wound dressing according to the present invention can absorb excess tissue fluid, maintain the wound in proper humidity, and does not over-dry the wound, thereby promoting wound healing. In addition, compared to the negative used in the prior art For wound treatment, the wound dressing of the present invention is also light and easy to operate.
雖然本創作已以實施方式揭露如上,然其並非用以限定本創作,以上所述之實施例僅係為說明本創作之技術思想及特點,其目的在使熟習此項技藝之人士能夠瞭解本創作之內容並據以實施,當不能以之限定本創作之專利範圍,即大凡依本創作所揭示之精神所作之均等變化或修飾,仍應涵蓋在本創作之專利範圍內,本創作之保護範圍當視後附之申請專利範圍所界定者為準。Although the present invention has been disclosed in the above embodiments, which are not intended to limit the present invention, the embodiments described above are merely illustrative of the technical idea and features of the present invention, and the purpose thereof is to enable those skilled in the art to understand the present invention. The content of the creation and implementation of it, when it is not possible to limit the scope of the patent of this creation, that is, the equivalent changes or modifications made by the spirit of the creation of this creation should still be covered in the scope of the patent of this creation, the protection of this creation The scope is subject to the definition of the scope of the patent application attached.
100‧‧‧傷口敷料100‧‧‧Wound dressing
110‧‧‧背材110‧‧‧ Backing
120‧‧‧吸收層120‧‧‧absorbing layer
130‧‧‧毛細微結構層130‧‧‧Capillary microstructure layer
H1、H2‧‧‧高度H1, H2‧‧‧ height
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103221183U TWM501839U (en) | 2014-11-28 | 2014-11-28 | Wound dressing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103221183U TWM501839U (en) | 2014-11-28 | 2014-11-28 | Wound dressing |
Publications (1)
Publication Number | Publication Date |
---|---|
TWM501839U true TWM501839U (en) | 2015-06-01 |
Family
ID=53936038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103221183U TWM501839U (en) | 2014-11-28 | 2014-11-28 | Wound dressing |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWM501839U (en) |
-
2014
- 2014-11-28 TW TW103221183U patent/TWM501839U/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5547197B2 (en) | Multilayer dressing, system, and method for applying reduced pressure to a tissue site | |
TWI595902B (en) | Portable negative-pressure device | |
JP2020072942A (en) | Dressing with fluid acquisition and distribution characteristic | |
TWM553191U (en) | Negative pressure wound dressing | |
JP6474731B2 (en) | Hygroscopic seal | |
US20210145648A1 (en) | Granulating Chronic Wound Dressing | |
TWM506601U (en) | Negative pressure wound dressing | |
US10004646B2 (en) | Methods for using polymer foam absorbent materials in wound dressings | |
US20110034892A1 (en) | Passive wound therapy device | |
JP2020523056A (en) | Wound dressing with odor absorption and increased water vapor permeability | |
BR112017004789B1 (en) | medical dressing and method of making a medical dressing | |
JP2013502983A (en) | Re-epithelial wound medical material and system | |
CN105596146B (en) | One kind compression negative-pressure vacuum system | |
CN104225768A (en) | Multilayer negative-pressure closed drainage wound protecting device | |
CN104188760A (en) | Dressing for overall absorption of viscous exudates and blood | |
CN104013493A (en) | Closed wound surface dressing device internally provided with washing instillation tubes | |
CN111329659A (en) | Micro-negative pressure wound exudate absorption dressing based on composition of various high polymer materials | |
US20160158066A1 (en) | Negative pressure wound dressing | |
CN204364238U (en) | Wound dressing | |
TWM525747U (en) | Trauma dressing structure | |
CN105434107A (en) | Silica gel vacuum sealing drainage dressing | |
US20220096728A1 (en) | Wound drain | |
CN212490402U (en) | Micro-negative pressure wound exudate absorption dressing based on composition of various high polymer materials | |
CN204501234U (en) | Negative pressure wound dressings | |
TWM501839U (en) | Wound dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4K | Expiration of patent term of a granted utility model |